Imunon, Inc. Increase (Decrease) in Deferred Liabilities
Imunon, Inc. (IMNN) reported Increase (Decrease) in Deferred Liabilities of -$8.43 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredLiabilities · last filed 2020-03-25
- Imunon, Inc. increase (decrease) in deferred liabilities for the quarter ending 2018-12-31 was -$2.42K.
- Imunon, Inc. increase (decrease) in deferred liabilities for the quarter ending 2018-09-30 was -$3.05K, a 108.29% decline year-over-year.
- Imunon, Inc. increase (decrease) in deferred liabilities for the quarter ending 2018-06-30 was -$1.48K, a 104.38% decline year-over-year.
- Imunon, Inc. increase (decrease) in deferred liabilities for the quarter ending 2018-03-31 was -$1.48K.
- Imunon, Inc. increase (decrease) in deferred liabilities for fiscal 2018 was -$8.43K, a 114.21% decline from fiscal 2017.
- Imunon, Inc. increase (decrease) in deferred liabilities for fiscal 2017 was $59.36K.
- Imunon, Inc. increase (decrease) in deferred liabilities for fiscal 2016 was -$35.24K.
- Imunon, Inc. increase (decrease) in deferred liabilities for fiscal 2015 was -$29.81K.
| Period end | Increase (Decrease) in Deferred Liabilities 3 month | Increase (Decrease) in Deferred Liabilities 6 month | Increase (Decrease) in Deferred Liabilities 9 month | Increase (Decrease) in Deferred Liabilities 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$2.42K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | -$5.48K derived: sum of 2 quarters · filed 2020-03-25 | -$6.95K derived: sum of 3 quarters · filed 2020-03-25 | -$8.43K 10-K · filed 2020-03-25 |
| 2018-09-30 | -$3.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$4.53K derived: sum of 2 quarters · filed 2019-11-14 | -$6.01K 10-Q · filed 2019-11-14 | -$7.98K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | -$1.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$2.96K 10-Q · filed 2019-08-14 | -$4.92K derived: sum of 3 quarters · filed 2019-08-14 | $31.91K derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | -$1.48K 10-Q · filed 2019-05-15 | -$3.45K derived: sum of 2 quarters · filed 2019-05-15 | $33.39K derived: sum of 3 quarters · filed 2019-05-15 | $67.14K derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | -$1.97K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $34.87K derived: sum of 2 quarters · filed 2019-03-29 | $68.62K derived: sum of 3 quarters · filed 2019-03-29 | $59.36K 10-K · filed 2019-03-29 |
| 2017-09-30 | $36.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $70.59K derived: sum of 2 quarters · filed 2018-11-14 | $61.33K 10-Q · filed 2018-11-14 | $52.06K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $33.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $24.49K 10-Q · filed 2018-08-14 | $15.22K derived: sum of 3 quarters · filed 2018-08-14 | $5.96K derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | -$9.26K 10-Q · filed 2018-05-11 | -$18.53K derived: sum of 2 quarters · filed 2018-05-11 | -$27.79K derived: sum of 3 quarters · filed 2018-05-11 | -$35.70K derived: sum of 4 quarters · filed 2018-05-11 |
| 2016-12-31 | -$9.26K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-27 | -$18.53K derived: sum of 2 quarters · filed 2018-03-27 | -$26.43K derived: sum of 3 quarters · filed 2018-03-27 | -$35.24K 10-K · filed 2018-03-27 |
| 2016-09-30 | -$9.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$17.17K derived: sum of 2 quarters · filed 2017-11-14 | -$25.98K 10-Q · filed 2017-11-14 | -$33.89K derived: sum of 4 quarters · filed 2017-11-14 |
| 2016-06-30 | -$7.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$16.72K 10-Q · filed 2017-08-14 | -$24.62K derived: sum of 3 quarters · filed 2017-08-14 | -$32.53K derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | -$8.81K 10-Q · filed 2017-05-12 | -$16.72K derived: sum of 2 quarters · filed 2017-05-12 | -$24.62K derived: sum of 3 quarters · filed 2017-05-12 | -$32.08K derived: sum of 4 quarters · filed 2017-05-12 |
| 2015-12-31 | -$7.91K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | -$15.81K derived: sum of 2 quarters · filed 2017-03-24 | -$23.26K derived: sum of 3 quarters · filed 2017-03-24 | -$29.81K 10-K · filed 2017-03-24 |
| 2015-09-30 | -$7.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$15.36K derived: sum of 2 quarters · filed 2016-11-10 | -$21.90K 10-Q · filed 2016-11-10 | -$28.45K derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | -$7.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$14.00K 10-Q · filed 2016-08-15 | -$20.55K derived: sum of 3 quarters · filed 2016-08-15 | -$27.09K derived: sum of 4 quarters · filed 2016-08-15 |
| 2015-03-31 | -$6.55K 10-Q · filed 2016-05-16 | -$13.10K derived: sum of 2 quarters · filed 2016-05-16 | -$19.64K derived: sum of 3 quarters · filed 2016-05-16 | -$25.73K derived: sum of 4 quarters · filed 2016-05-16 |
| 2014-12-31 | -$6.55K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$13.10K derived: sum of 2 quarters · filed 2016-03-30 | -$19.19K derived: sum of 3 quarters · filed 2016-03-30 | -$24.38K 10-K · filed 2016-03-30 |
| 2014-09-30 | -$6.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$12.64K derived: sum of 2 quarters · filed 2015-11-05 | -$17.82K 10-Q · filed 2015-11-05 | -$23.01K derived: sum of 4 quarters · filed 2016-03-30 |
| 2014-06-30 | -$6.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$11.28K 10-Q · filed 2015-08-10 | -$16.47K derived: sum of 3 quarters · filed 2016-03-30 | -$21.66K derived: sum of 4 quarters · filed 2016-03-30 |
| 2014-03-31 | -$5.19K 10-Q · filed 2015-05-11 | -$10.37K derived: sum of 2 quarters · filed 2016-03-30 | -$15.56K derived: sum of 3 quarters · filed 2016-03-30 | -$20.30K derived: sum of 4 quarters · filed 2016-03-30 |
| 2013-12-31 | -$5.19K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$10.38K derived: sum of 2 quarters · filed 2016-03-30 | -$15.11K derived: sum of 3 quarters · filed 2016-03-30 | -$18.94K 10-K · filed 2016-03-30 |
| 2013-09-30 | -$5.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$9.92K derived: sum of 2 quarters · filed 2014-11-10 | -$13.75K 10-Q · filed 2014-11-10 | |
| 2013-06-30 | -$4.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$8.56K 10-Q · filed 2014-08-07 | ||
| 2013-03-31 | -$3.83K 10-Q · filed 2014-05-08 | |||
| 2012-12-31 | $55.26K 10-K · filed 2015-03-12 | |||
| 2011-12-31 | $65.47K 10-K · filed 2014-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |